Vol 5, No 1 (2004): Practical Diabetology
Review article
Published online: 2004-02-02

open access

Page views 634
Article views/downloads 1569
Get Citation

Connect on Social Media

Connect on Social Media

Hormonal replacement therapy in postmenopausal diabetic women

Andrzej Milewicz, Diana Jędrzejuk
Diabetologia Praktyczna 2004;5(1):41-44.

Abstract

In postmenopausal women due to the lack of the sex hormones occur the metabolic changes. Visceral obesity, insulin resistance, dyslipidemia, hypertension are the risk factors for cardiovascular diseases. These factors create the menopausal metabolic syndrome (syndrome X or syndrome W). After menopause the number of women with diabetes mellitus is growing up. Menopause and diabetes cause to higher mortality of cardiovascular diseases. Hormonal replacement therapy in diabetic postmenopausal women should be “tailored”. Diabetic postmenopausal women often suffer from endometrial carcinoma, fatty liver, cholecystolithiasis, hypertension, hipertriglycerydemia, insulin resistance. Hormone replacement therapy should be provided transdermal to avoid the above concomitant illnesses. The progestagen which should be prescribed by intact uterus should bind only progesterone’s receptor (not glycocorticosteroid’s receptor).

Article available in PDF format

View PDF Download PDF file